Malignant Peritoneal Mesothelioma

Treatment Options and Survival

Silja A. S. Salo, Ilkka Ilonen, Sanna Laaksonen, Marjukka Myllärniemi, Jarmo A. Salo, Tuomo Rantanen

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalAnticancer Research
Volume39
Issue number2
Pages (from-to)839-845
Number of pages7
ISSN0250-7005
DOIs
Publication statusPublished - Feb 2019
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Mesothelioma
  • peritoneal mesothelioma
  • treatment
  • survival
  • Finland
  • CRS
  • HIPEC
  • chemotherapy
  • radiotherapy
  • asbestos exposure
  • HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY
  • LONG-TERM SURVIVAL
  • CYTOREDUCTIVE SURGERY
  • SYSTEMIC CHEMOTHERAPY
  • MANAGEMENT
  • EPIDEMIOLOGY
  • UPDATE
  • 3122 Cancers

Cite this

Salo, Silja A. S. ; Ilonen, Ilkka ; Laaksonen, Sanna ; Myllärniemi, Marjukka ; Salo, Jarmo A. ; Rantanen, Tuomo. / Malignant Peritoneal Mesothelioma : Treatment Options and Survival. In: Anticancer Research. 2019 ; Vol. 39, No. 2. pp. 839-845.
@article{93701009f9d84b42aa1169654ccdce9d,
title = "Malignant Peritoneal Mesothelioma: Treatment Options and Survival",
keywords = "Mesothelioma, peritoneal mesothelioma, treatment, survival, Finland, CRS, HIPEC, chemotherapy, radiotherapy, asbestos exposure, HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY, LONG-TERM SURVIVAL, CYTOREDUCTIVE SURGERY, SYSTEMIC CHEMOTHERAPY, MANAGEMENT, EPIDEMIOLOGY, UPDATE, 3122 Cancers",
author = "Salo, {Silja A. S.} and Ilkka Ilonen and Sanna Laaksonen and Marjukka Myll{\"a}rniemi and Salo, {Jarmo A.} and Tuomo Rantanen",
year = "2019",
month = "2",
doi = "10.21873/anticanres.13183",
language = "English",
volume = "39",
pages = "839--845",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH",
number = "2",

}

Malignant Peritoneal Mesothelioma : Treatment Options and Survival. / Salo, Silja A. S.; Ilonen, Ilkka; Laaksonen, Sanna; Myllärniemi, Marjukka; Salo, Jarmo A.; Rantanen, Tuomo.

In: Anticancer Research, Vol. 39, No. 2, 02.2019, p. 839-845.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Malignant Peritoneal Mesothelioma

T2 - Treatment Options and Survival

AU - Salo, Silja A. S.

AU - Ilonen, Ilkka

AU - Laaksonen, Sanna

AU - Myllärniemi, Marjukka

AU - Salo, Jarmo A.

AU - Rantanen, Tuomo

PY - 2019/2

Y1 - 2019/2

KW - Mesothelioma

KW - peritoneal mesothelioma

KW - treatment

KW - survival

KW - Finland

KW - CRS

KW - HIPEC

KW - chemotherapy

KW - radiotherapy

KW - asbestos exposure

KW - HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY

KW - LONG-TERM SURVIVAL

KW - CYTOREDUCTIVE SURGERY

KW - SYSTEMIC CHEMOTHERAPY

KW - MANAGEMENT

KW - EPIDEMIOLOGY

KW - UPDATE

KW - 3122 Cancers

U2 - 10.21873/anticanres.13183

DO - 10.21873/anticanres.13183

M3 - Article

VL - 39

SP - 839

EP - 845

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2

ER -